SCHEMBL22907989

SCHEMBL22907989

c1ccc(-c2ccccc2-c2c3ccccc3c(-c3cccc4c3oc3ccc5oc6ccccc6c5c34)c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 2/20 0.41
▸ CDC14A Q9UNH5 2/20 0.41
▸ ALOX5 P09917 2/20 0.40
▸ MAPT P10636 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ CSF1R P07333 1/20 0.36
▸ PDGFRB P09619 1/20 0.36
▸ KIT P10721 1/20 0.36
▸ FLT3 P36888 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ PRKDC P78527 2/20 0.36
▸ WEE1 P30291 1/20 0.35
▸ GGPS1 O95749 1/20 0.35
▸ CA1 P00915 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ NTRK1 P04629 1/20 0.35
▸ PLK3 Q9H4B4 1/20 0.35
▸ MAOA P21397 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27265062 0.93 CDC14B (0.43) CDC14BCDC14AALOX5MAPTMEN1
SCHEMBL24519112 0.93 CDC14B (0.43) CDC14BCDC14AALOX5MAPTMEN1
SCHEMBL22908071 0.93 ALOX5 (0.41) CDC14BCDC14AALOX5MAPTMEN1
SCHEMBL24518968 0.91 ALOX5 (0.44) CDC14BCDC14AALOX5MAPTMEN1
SCHEMBL22908036 0.90 ALOX5 (0.43) CDC14BCDC14AALOX5MAPTMEN1
SCHEMBL24518914 0.90 ALOX5 (0.51) CDC14BCDC14AALOX5MAPTMEN1
SCHEMBL24663074 0.89 ALOX5 (0.39) CDC14BCDC14AALOX5PRKDCWEE1
SCHEMBL24663076 0.89 CDC14B (0.40) CDC14BCDC14AALOX5MAPTMEN1
SCHEMBL24662834 0.89 ALOX5 (0.45) CDC14BCDC14AALOX5MAPTMEN1
SCHEMBL24662702 0.88 CDC14B (0.37) CDC14BCDC14AALOX5MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4245743-A1 METHOD FOR PREPARATION OF DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND, AND COMPOSITION Lg Chem, Ltd. (KR) 2023-09-20 — — EP disclosed
WO-2023172110-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2023-09-14 — — WO disclosed
WO-2022169218-A1 METHOD FOR PREPARATION OF DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND, AND COMPOSITION 주식회사 엘지화학 2022-08-11 — — WO disclosed
US-20210020842-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2021-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210020842-A1 ORGANIC LIGHT-EMITTING DEVICE OR10J3, OR51E2, LOXL1 CDC14B 3572/4885CDC14A 3899/4885ALOX5 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback